We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi Holds Off Generic Rivals in Eloxatin Cancer Drug Case
Sanofi Holds Off Generic Rivals in Eloxatin Cancer Drug Case
September 15, 2009
Generic-drug makers seeking permission to market versions of Sanofi-Aventis’ cancer treatment Eloxatin were dealt a setback when a federal appeals court vacated a ruling in their favor.